TY - JOUR T1 - Medication review in hospitalised older people: what have we learnt? JF - BMJ Quality & Safety JO - BMJ Qual Saf SP - 853 LP - 856 DO - 10.1136/bmjqs-2022-014882 VL - 31 IS - 12 AU - Nina Lee Barnett AU - Lelly Oboh Y1 - 2022/12/01 UR - http://qualitysafety.bmj.com/content/31/12/853.abstract N2 - Person-centred care is considered essential to clinical practice by regulatory and professional bodies around the world. For example, in the UK, the General Medical Council, General Pharmaceutical Council, Care Quality Commission and National Institute for Health and Care Excellence strongly advocate for it. The paper by Thevelin and colleagues1, in this edition of BMJ Quality & Safety, offers us the opportunity to reflect on medication review from the perspectives of both patients and healthcare professionals. In addition, it challenges us to consider how we can do better for our patients using a patient-centred approach through making shared decisions about changes to their medicines.The OPERAM trial2 evaluated the impact of a complex intervention of medication review with shared decision making on drug-related readmissions for older people with multi-morbidity and polypharmacy (>5 medicines) who were inpatients in four European countries (Belgium, Ireland, Switzerland and The Netherlands). The study demonstrated that these reviews, undertaken jointly by pharmacists and doctors, reduced inappropriate prescribing but had no significant effect on drug-related hospital admissions.To improve our understanding of the contextual factors and mechanisms that influence the effectiveness of medication reviews, Thevelin and colleagues used a multi-centre mixed-methods study, embedded in the OPERAM trial, exploring the experiences of patients in relation to hospital-initiated medication changes in depth. The investigators performed semi-structured interviews with a purposive sample of 48 patients across the four countries, starting 12 months into the OPERAM trial. The interviews were undertaken within a month of discharge and included a subset of patients, from the OPERAM trial, who had medication changes during their hospital stay and were willing to share their experiences. The interviews covered relevant aspects of the UK NHS Patient Experience Framework3 and the OPERAM intervention components. As patients’ beliefs about their medicines can affect their acceptance … ER -